ARMOUR Residential REIT Inc (ARR) concluded trading on Wednesday at a closing price of $17.62, with 4.05 million shares of worth about $71.38 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.38% during that period and on March 26, 2025 the price saw a loss of about -2.97%. Currently the company’s common shares owned by public are about 79.97M shares, out of which, 79.65M shares are available for trading.
Stock saw a price change of -5.67% in past 5 days and over the past one month there was a price change of -6.48%. Year-to-date (YTD), ARR shares are showing a performance of -6.57% which decreased to -8.42% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $17.35 but also hit the highest price of $21.93 during that period. The average intraday trading volume for ARMOUR Residential REIT Inc shares is 2.58 million. The stock is currently trading -5.44% below its 20-day simple moving average (SMA20), while that difference is down -5.82% for SMA50 and it goes to -9.41% lower than SMA200.
ARMOUR Residential REIT Inc (NYSE: ARR) currently have 79.97M outstanding shares and institutions hold larger chunk of about 41.58% of that.
The stock has a current market capitalization of $1.41B and its 3Y-monthly beta is at 1.23. It has posted earnings per share of -$0.44 in the same period. It has a debt-to-equity ratio of 7.87. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ARR, volatility over the week remained 1.93% while standing at 1.90% over the month.
Stock’s fiscal year EPS is expected to rise by 1.36% while it is estimated to increase by 0.22% in next year. EPS is likely to shrink at an annualized rate of -5.85% for next 5-years, compared to annual growth of 53.38% made by the stock over the past 5-years.
Coverage by Janney stated ARMOUR Residential REIT Inc (ARR) stock as a Neutral in their note to investors on June 06, 2024, suggesting a price target of $20 for the stock. On December 06, 2023, UBS Initiated their recommendations, while on February 22, 2022, B. Riley Securities Reiterated their ratings for the stock with a price target of $9.50. Stock get a Neutral rating from B. Riley Securities on July 14, 2021.
